ORBIMED ADVISORS LLC: ABCL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ABCL, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 0 ABCL shares at 2025-09-30 per its 13F-HR filed 2025-11-14.
the latest 13F is the newest step
- period ended2025-09-3013F 0 sharesChange vs previous 13F -3,344,568 shares
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-06-3013F 3,344,568 sharesChange vs previous 13F -836,200 shares
0.29% of the 13F portfolio, value $11,471,868.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,180,768 sharesChange vs previous 13F 0 shares
0.22% of the 13F portfolio, value $9,323,113.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 4,180,768 sharesChange vs previous 13F 0 shares
0.25% of the 13F portfolio, value $12,249,650.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 4,180,768 sharesChange vs previous 13F not available
0.2% of the 13F portfolio, value $10,869,997.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).